TRAXV NASDAQ
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
1W: +13.6%
YTD: +8.2%
$22.51
Last traded 2026-05-04 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$782.2M
52W Range14.79-26.8
Volume20,877
Avg Volume265,533
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODaniel R. Faga
SectorHealthcare
IndustryBiotechnology
IPO Date2026-04-06
10770 Wateridge Circle
San Diego, CA 92121
US
San Diego, CA 92121
US
About First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.
Recent Insider Trades
No insider trades found